1887

Abstract

Recently, HBZ has been reported to play an important role in the proliferation of adult T-cell leukaemia (ATL) cells and might be a target of novel therapy for ATL. To develop a novel immunotherapy for ATL, we verified the feasibility of cellular immunotherapy targeting HBZ. We established an HBZ-specific and HLA-A*0201-restricted cytotoxic T lymphocyte (CTL) clone. Detailed study using this CTL clone clearly showed that HBZ is certainly an immunogenic protein recognizable by human CTLs; however, HBZ-specific CTLs could not lyse ATL cells. Failure of HBZ-specific CTLs to recognize human T-cell leukemia virus type 1 (HTLV-1)-infected cells might be due to a low level of HBZ protein expression in ATL cells and resistance of HTLV-1-infected cells to CTL-mediated cytotoxicity. Although HBZ plays an important role in the proliferation of HTLV-1-infected cells, it may also provide a novel mechanism that allows them to evade immune recognition.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.010199-0
2009-08-01
2019-11-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/90/8/1806.html?itemId=/content/journal/jgv/10.1099/vir.0.010199-0&mimeType=html&fmt=ahah

References

  1. Azuma, T., Otsuki, T., Kuzushima, K., Froelich, C., Fujita, S. & Yasukawa, M. ( 2004; ). Myeloma cells are highly sensitive to granule exocytosis pathway mediated by WT1-specific cytotoxic T lymphocytes. Clin Cancer Res 10, 7402–7412.[CrossRef]
    [Google Scholar]
  2. Balaji, K. N., Schaschke, N., Machleidt, W., Catalfamo, M. & Henkart, P. A. ( 2002; ). Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. J Exp Med 196, 493–503.[CrossRef]
    [Google Scholar]
  3. Basbous, J., Arpin, C., Gaudray, G., Piechaczyk, M., Devaux, C. & Mesnard, J. M. ( 2003; ). The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity. J Biol Chem 278, 43620–43627.[CrossRef]
    [Google Scholar]
  4. Bird, C. H., Sutton, V. R., Sun, J., Hirst, C. E., Novak, A., Kumar, S., Trapani, J. A. & Bird, P. I. ( 1998; ). Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol Cell Biol 18, 6387–6398.
    [Google Scholar]
  5. Fujiwara, H., Ozaki, A., Yoshimitsu, M., Hamada, H., Masamoto, I., Matsushita, K., Yasukawa, M. & Tei, C. ( 2008; ). Allogeneic stem cell transplantation for refractory adult T-cell leukemia using a non-T-cell-depleted HLA-incompatible family donor graft, with reference to the grown-up child donor to parent recipient setting: report of a pilot study. Int J Hematol 87, 319–326.[CrossRef]
    [Google Scholar]
  6. Gaudray, G., Gachon, F., Basbous, J., Biard-Piechaczyk, M., Devaux, C. & Mesnard, J. M. ( 2002; ). The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol 76, 12813–12822.[CrossRef]
    [Google Scholar]
  7. Harashima, N., Kurihara, K., Utsunomiya, A., Tanosaki, R., Hanabuchi, S., Masuda, M., Ohashi, T., Fukui, F., Hasegawa, A. & other authors ( 2004; ). Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res 64, 391–399.[CrossRef]
    [Google Scholar]
  8. Jiang, S. B., Ojcius, D. M., Persechini, P. M. & Young, J. D. ( 1990; ). Resistance of cytolytic lymphocytes to perforin-mediated killing. Inhibition of perforin binding activity by surface membrane proteins. J Immunol 144, 998–1003.
    [Google Scholar]
  9. Kuzushima, K., Hayashi, N., Kimura, H. & Tsurumi, T. ( 2001; ). Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8+ T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay. Blood 98, 1872–1881.[CrossRef]
    [Google Scholar]
  10. Lehmann, C., Zeis, M., Schmitz, N. & Uharek, L. ( 2000; ). Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells. Blood 96, 594–600.
    [Google Scholar]
  11. Lemasson, I., Lewis, M. R., Polakowski, N., Hivin, P., Cavanagh, M. H., Thébault, S., Barbeau, B., Nyborg, J. K. & Mesnard, J. M. ( 2007; ). HTLV-1 bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J Virol 81, 1543–1553.[CrossRef]
    [Google Scholar]
  12. Muller, C. & Tschopp, J. ( 1994; ). Resistance of CTL to perforin-mediated lysis. Evidence for a lymphocyte membrane protein interacting with perforin. J Immunol 153, 2470–2478.
    [Google Scholar]
  13. Odeberg, J., Browne, H., Metkar, S., Froelich, C. J., Brandén, L., Cosman, D. & Söderberg-Nauclér, C. ( 2003; ). The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins. J Virol 77, 4539–4545.[CrossRef]
    [Google Scholar]
  14. Ohminami, H., Yasukawa, M. & Fujita, S. ( 2000; ). HLA class I-restricted lysis of leukemia cells by a CD8+ cytotoxic T-lymphocyte specific for WT1 peptide. Blood 95, 286–293.
    [Google Scholar]
  15. Satou, Y. & Matsuoka, M. ( 2007; ). Implication of the HTLV-I bZIP factor gene in the leukemogenesis of adult T-cell leukemia. Int J Hematol 86, 107–112.[CrossRef]
    [Google Scholar]
  16. Satou, Y., Yasunaga, J., Yoshida, M. & Matsuoka, M. ( 2006; ). HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci U S A 103, 720–725.[CrossRef]
    [Google Scholar]
  17. Suemori, K., Fujiwara, H., Ochi, T., Azuma, T., Yamanouchi, J., Narumi, H., Yakushijin, Y., Hato, T., Hasegawa, H. & Yasukawa, M. ( 2008; ). Identification of an epitope derived from CML66, a novel tumor-associated antigen broadly expressed in human leukemia, recognized by HLA-A*2402-restricted cytotoxic T lymphocytes. Cancer Sci 99, 1414–1419.[CrossRef]
    [Google Scholar]
  18. Taylor, G. P. & Matsuoka, M. ( 2005; ). Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene 24, 6047–6057.[CrossRef]
    [Google Scholar]
  19. Utsunomiya, A., Miyazaki, Y., Takatsuka, Y., Hanada, S., Uozumi, K., Yashiki, S., Tara, M., Kawano, F., Saburi, Y. & other authors ( 2001; ). Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 27, 15–20.[CrossRef]
    [Google Scholar]
  20. Yasukawa, M., Ohminami, H., Yakushijin, Y., Arai, J., Hasegawa, A., Ishida, Y. & Fujita, S. ( 1999; ). Fas-independent cytotoxicity mediated by human CD4+ CTL directed against herpes simplex virus-infected cells. J Immunol 162, 6100–6106.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.010199-0
Loading
/content/journal/jgv/10.1099/vir.0.010199-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error